Vistin Pharma ASA (OSL:VISTN)

Norway · Delayed Price · Currency is NOK

20.50

-0.20 (-0.97%)

At close: Jun 3, 2026

Revenue by Segment

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals	452.29M	429.50M	438.33M	304.85M	278.62M
Pharmaceuticals Growth	5.31%	-2.01%	43.78%	9.41%	9.73%
Total	452.29M	429.50M	438.33M	304.85M	278.62M
Total Growth	5.31%	-2.01%	43.78%	9.41%	9.73%

Revenue by Geography

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Africa	49.64M	42.91M	65.70M	37.48M	57.93M
Africa Growth	15.70%	-34.69%	75.29%	-35.31%	-6.04%
Europe	358.27M	348.82M	338.87M	195.98M	170.40M
Europe Growth	2.71%	2.94%	72.91%	15.01%	23.16%
Asia	41.05M	32.99M	29.32M	19.80M	23.74M
Asia Growth	24.45%	12.50%	48.11%	-16.59%	20.29%
North and South America	3.33M	4.38M	1.51M	34.42M	23.74M
North and South America Growth	-23.99%	191.10%	-95.63%	44.94%	-28.95%
Total	452.29M	429.09M	435.39M	287.68M	275.81M
Total Growth	5.41%	-1.45%	51.35%	4.30%	8.95%

Source: S&P Global Market Intelligence.